0.5% Levofloxacin Hydrochloride Ear Drops, covered by national medical insurance system category B directory, which is developed by Relin Medicine as the first product of 0.5% levofloxacin hydrochloride ear drops worldwide. Listed for more than 10 years and is recommended by guideline as a first-line medication for external otitis and acute and chronic suppurative otitis media.